Medicine & Life Sciences
B-Cell Lymphoma
100%
Non-Hodgkin's Lymphoma
60%
tisagenlecleucel
60%
Progression-Free Survival
59%
Chimeric Antigen Receptors
53%
Survival
49%
Langerhans Cell Histiocytosis
41%
Sarcopenia
40%
Hematopoietic Stem Cell Transplantation
34%
Cell- and Tissue-Based Therapy
33%
Natural History
32%
Lymphoma
26%
Retrospective Studies
25%
T-Lymphocytes
24%
Outpatients
24%
Lung
17%
Inpatients
17%
Therapeutics
16%
Neoplasms
14%
Confidence Intervals
14%
Drug Therapy
13%
Lymphoma, Large B-Cell, Diffuse
13%
L-Lactate Dehydrogenase
12%
Cyclophosphamide
11%
Mantle-Cell Lymphoma
10%
Rituximab
9%
Vincristine
9%
Follicular Lymphoma
9%
Intensive Care Units
9%
Length of Stay
9%
Prednisone
9%
Body Composition
9%
Doxorubicin
8%
Hematologic Neoplasms
8%
Multiple Myeloma
7%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7%
Practice Guidelines
7%
Skeletal Muscle
7%
Patient Selection
7%
axicabtagene ciloleucel
6%
Comorbidity
6%
B-Lymphocytes
6%
Nutritional Requirements
6%
Karnofsky Performance Status
5%
Direction compound
5%
Cytokine Release Syndrome
5%
Febrile Neutropenia
5%
Neurotoxicity Syndromes
5%
Mucositis
5%
Muscles
5%